Key facts
- Notable investors include Opportunity Calgary Investment Fund, Bonnefield.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Solvet
- ·The full record, as it builds
Funding rounds
No funding rounds for Solvet are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Solvet
Manufacturer of veterinary pharmaceuticals and animal health products intended for veterinarians, farmers, and pet owners across Canada. The company offers products including antimicrobial, anti-inflammatory, reproduction management, gastrointestinal, antiseptics, and other related products, thereby helping maintain and improve animal health and welfare.
- Sector
- Business Products and Services (B2B)
- HQ
- Calgary, Canada
- Founded
- 2009
- Employees
- 66
- Website
- solvet.ca/
- Ownership
- Privately Held (backing)
Solvet doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Solvet shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Solvet in its N-PORT filings yet. We sweep new filings monthly.